Ceftriaxone
Active substance: ceftriaxone
INJECTION, POWDER, FOR SOLUTION · CEFTRIAXONE SODIUM 250 mg/1
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CEFTRIAXONE SODIUM · 250 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 125 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-41b6-7ae7-be51-ca8403464bb3,01a1208c-5b63-76c5-9c24-f32c4694a291,01a1208c-5b67-7129-afa7-abccb178a6fb,01a1208c-6148-7bf7-aa26-60401e829a7e,01a1208c-b6ab-7774-bf5e-14e35edec76a;count=55 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0143-9859
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS
Sources
- product · openFDA NDC · 0143-9859 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0143-9859 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0143-9859 · Verified 2026-10-09 · open in source